Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Biorce and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR

Biorce

Barcelona, Spain
VISIT WEBSITE
Biorce is a Barcelona-based healthtech company that provides an AI-powered platform, known as Aika (formerly referred to as Jarvis), designed to streamline clinical trial design and execution. The platform assists pharmaceutical companies, biotech firms, and CROs by automating protocol development, feasibility assessments, and regulatory planning, aiming to reduce trial preparation time and operational risks. By leveraging a vast dataset of over one million clinical trials, Biorce's technology enables data-driven decision-making, optimized patient matching, and the creation of regulator-ready protocols. The company is focused on accelerating time-to-market for new therapies and improving the efficiency of global clinical development processes.
CLASSIFICATION
Company Type:Digital Health
Therapeutic Areas:-
Industry:Digital Health
Sub-Industry:Clinical Trial AI Software
SIZE & FINANCIALS
Employees:51-200
Founded:2024
Ownership:private
Status:operating
FUNDING
Stage:Series A
Total Raised:$52.5M
Investors:TZR Capital, Endeavour Catalyst, Norrsken VC, Mustard Seed Maze, Nik Storonsky, Paulo Rosado
0
COMPETITION
Position:Emerging
LEADERSHIP
Key Executives:
Pedro Coelho - CEO
Scientific Founders:Pedro Coelho, Diogo Pisoeiro, Clara Bernardes, José Faria
LINKS
Website:biorce.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Biorce. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.